Risk Factors for Major Hemorrhage Among Patients Receiving Dabigatran Across the Spectrum of CKD Not Requiring Dialysis Therapy

Am J Kidney Dis. 2021 Jul;78(1):151-153. doi: 10.1053/j.ajkd.2020.09.018. Epub 2020 Dec 2.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Antithrombins / adverse effects*
  • Dabigatran / adverse effects*
  • Female
  • Hemorrhage / chemically induced*
  • Hemorrhage / epidemiology
  • Humans
  • Male
  • Prospective Studies
  • Renal Dialysis
  • Renal Insufficiency, Chronic*
  • Risk Factors
  • Severity of Illness Index

Substances

  • Antithrombins
  • Dabigatran